A multicentre parallel-group randomised trial assessing multiparametric MRI characterisation and image-guided biopsy of prostate in men suspected of having prostate cancer: MULTIPROS study protocol

BACKGROUND: There is growing evidence suggesting that multiparametric magnetic resonance imaging (mpMRI) is a marker for prostate cancer (PCa) aggressiveness and could be used to plan treatment. Improving early detection of clinically significant PCa with pre-biopsy mpMRI would very likely have adva...

Descripción completa

Detalles Bibliográficos
Autores principales: Szewczyk-Bieda, Magdalena, Wei, Cheng, Coll, Katherine, Gandy, Stephen, Donnan, Peter, Ragupathy, Senthil Kumar Arcot, Singh, Paras, Wilson, Jennifer, Nabi, Ghulam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868804/
https://www.ncbi.nlm.nih.gov/pubmed/31752954
http://dx.doi.org/10.1186/s13063-019-3746-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868804/
https://www.ncbi.nlm.nih.gov/pubmed/31752954
http://dx.doi.org/10.1186/s13063-019-3746-0

Ejemplares similares